Literature DB >> 20569952

Distribution of body mass index in the forensic victim population: comparison with the general population and relation to manner of death.

Anny Godin1, Margaret Redpath, Jean-Pierre Guay, Anny Sauvageau.   

Abstract

Despite a dramatic increase in the worldwide prevalence of overweight and obese people in recent years, the implication of this epidemic on forensic practice has barely been studied. Over a one-year period, all autopsy cases performed on adult victims in the province of Quebec (Canada) were retrospectively reviewed (582 cases). In the forensic population, manner of death differed in relation to BMI: underweight people most commonly died of natural causes, whereas normal weight, overweight and obese individuals most commonly died as the result of an accident. Results also revealed an over-representation of underweight victims and under-representation of overweight victims in the forensic population compared to the population of both Quebec and Canada. The latter is particularly worrisome considering it suggests that overweight corpses are less frequently referred for an autopsy. It is important to emphasize to forensic teams that just because an obese person is more likely to suffer from health problems that can lead to death, does not mean a natural death has occurred. Obese people are equally susceptible to unnatural causes of death and it is crucial to maintain an adequate level of suspicion while investigating the cases of these individuals. Copyright 2010 Elsevier Ltd and Faculty of Forensic and Legal Medicine. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20569952     DOI: 10.1016/j.jflm.2010.03.002

Source DB:  PubMed          Journal:  J Forensic Leg Med        ISSN: 1752-928X            Impact factor:   1.614


  1 in total

1.  Anthropometrical differences between suicide and other non-natural death circumstances: an autopsy study.

Authors:  Benno Flaig; Barbara Zedler; Hanns Ackermann; Hansjürgen Bratzke; Markus Parzeller
Journal:  Int J Legal Med       Date:  2012-11-09       Impact factor: 2.686

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.